• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性心肌病。

Diabetic cardiomyopathy.

机构信息

Servicio de Medicina Interna, Fundación Jiménez Díaz, Madrid, Spain.

Servicio de Medicina Interna, Hospital Vega Baja, Orihuela, Alicante, Spain.

出版信息

Rev Clin Esp (Barc). 2022 Feb;222(2):100-111. doi: 10.1016/j.rceng.2019.10.012. Epub 2020 Oct 23.

DOI:10.1016/j.rceng.2019.10.012
PMID:35115137
Abstract

The relationship between diabetes and heart failure is complex and bidirectional. Nevertheless, the existence of a cardiomyopathy attributable exclusively to diabetes has been and is still the subject of controversy, due, among other reasons, to a lack of a consensus definition. There is also no unanimous agreement in terms of the physiopathogenic findings that need to be present in the definition of diabetic cardiomyopathy or on its classification, which, added to the lack of diagnostic methods and treatments specific for this disease, limits its general understanding. Studies conducted on diabetic cardiomyopathy, however, suggest a unique physiopathogenesis different from that of other diseases. Similarly, new treatments have been shown to play a potential role in this disease. The following review provides an update on diabetic cardiomyopathy.

摘要

糖尿病与心力衰竭之间的关系复杂且相互影响。然而,由于缺乏共识定义等原因,单纯由糖尿病引起的心肌病的存在一直是且仍然是一个有争议的话题。在定义糖尿病性心肌病或对其进行分类时,需要存在哪些病理生理发现方面也没有一致的意见,加上缺乏针对这种疾病的诊断方法和治疗方法,这限制了对它的普遍理解。然而,对糖尿病性心肌病的研究表明,其病理生理学机制与其他疾病不同。同样,新的治疗方法也显示出在这种疾病中有潜在作用。以下综述介绍了糖尿病性心肌病的最新研究进展。

相似文献

1
Diabetic cardiomyopathy.糖尿病性心肌病。
Rev Clin Esp (Barc). 2022 Feb;222(2):100-111. doi: 10.1016/j.rceng.2019.10.012. Epub 2020 Oct 23.
2
Diabetic cardiomyopathy.糖尿病性心肌病
Rev Clin Esp. 2020 Feb 24. doi: 10.1016/j.rce.2019.10.013.
3
Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.糖尿病心肌病:定义、诊断和治疗意义。
Heart Fail Clin. 2019 Jul;15(3):341-347. doi: 10.1016/j.hfc.2019.02.003. Epub 2019 Apr 5.
4
Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.糖尿病与慢性心力衰竭:从糖尿病性心肌病到治疗方法
Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):38-50. doi: 10.2174/1871530311313010006.
5
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.潜在机制对糖尿病性心肌病的识别和管理的影响。
J Am Coll Cardiol. 2018 Jan 23;71(3):339-351. doi: 10.1016/j.jacc.2017.11.019.
6
Cardiovascular diagnostic methods in patients with diabetes mellitus. A review.糖尿病患者的心血管诊断方法。综述。
Gac Med Mex. 2023;159(3):247-254. doi: 10.24875/GMM.22000383.
7
Heartbeat: Diabetes and heart failure.心跳:糖尿病与心力衰竭。
Heart. 2017 Mar;103(5):327-328. doi: 10.1136/heartjnl-2017-311280.
8
[Diabetic cardiomyopathy/heart failure: news regarding etiology, diagnosis, therapy].[糖尿病性心肌病/心力衰竭:关于病因、诊断、治疗的新进展]
Dtsch Med Wochenschr. 2014 Oct;139(40):2006-9. doi: 10.1055/s-0034-1387225. Epub 2014 Sep 25.
9
Diabetic cardiomyopathy.糖尿病性心肌病。
J Card Fail. 2010 Dec;16(12):971-9. doi: 10.1016/j.cardfail.2010.07.249.
10
Diabetic cardiomyopathy: Clinical phenotype and practice.糖尿病心肌病:临床表型与实践。
Front Endocrinol (Lausanne). 2022 Dec 7;13:1032268. doi: 10.3389/fendo.2022.1032268. eCollection 2022.

引用本文的文献

1
Integrative transcriptomic and machine learning analyses identify HDAC9 as a key regulator of mitochondrial dysfunction and senescence-associated inflammation in diabetic nephropathy.综合转录组学和机器学习分析确定HDAC9是糖尿病肾病中线粒体功能障碍和衰老相关炎症的关键调节因子。
Front Immunol. 2025 Aug 29;16:1627173. doi: 10.3389/fimmu.2025.1627173. eCollection 2025.
2
Transcriptome analysis of serum biomarker, shared gene signature and pharmacological targets between diabetic cardiomyopathy and nephropathy.糖尿病性心肌病与肾病之间血清生物标志物、共享基因特征及药理靶点的转录组分析
Biochem Biophys Rep. 2025 Aug 2;43:102194. doi: 10.1016/j.bbrep.2025.102194. eCollection 2025 Sep.
3
The role of Nrf2 signaling pathway in diabetic cardiomyopathy: from pathogenesis to traditional Chinese medicine interventions.
Nrf2信号通路在糖尿病性心肌病中的作用:从发病机制到中医干预
Front Cardiovasc Med. 2025 Jul 14;12:1492499. doi: 10.3389/fcvm.2025.1492499. eCollection 2025.
4
Morphological Features of the Myocardium in db/db Mice with Genetically Determined Leptin Resistance and Glucose Metabolism Disorders after Systematic Administration of Recombinant Apolipoprotein A-I.重组载脂蛋白A-I全身给药后,具有遗传决定的瘦素抵抗和葡萄糖代谢紊乱的db/db小鼠心肌的形态学特征
Bull Exp Biol Med. 2025 May;179(1):154-161. doi: 10.1007/s10517-025-06451-6. Epub 2025 Jul 19.
5
Ferritinophagy in cardiovascular diseases: mechanisms and potential therapy.心血管疾病中的铁蛋白自噬:机制与潜在治疗方法
Mol Cell Biochem. 2025 Jun 20. doi: 10.1007/s11010-025-05301-3.
6
The cGAS/STING Pathway: Friend or Foe in Regulating Cardiomyopathy.cGAS/STING信号通路:调控心肌病的帮手还是敌人?
Cells. 2025 May 25;14(11):778. doi: 10.3390/cells14110778.
7
Unlocking the therapeutic potential of lncRNA FENDRR in DCM: novel targets and insights via the miR-296-5p/HMGA1 axis.解锁长链非编码RNA FENDRR在扩张型心肌病中的治疗潜力:通过miR-296-5p/HMGA1轴的新靶点及见解
J Cardiothorac Surg. 2025 May 31;20(1):254. doi: 10.1186/s13019-025-03477-9.
8
Identification of metabolic pathways and serum biomarkers in diabetic cardiomyopathy using untargeted metabolomics.使用非靶向代谢组学鉴定糖尿病性心肌病中的代谢途径和血清生物标志物
Sci Rep. 2025 May 28;15(1):18718. doi: 10.1038/s41598-025-98753-y.
9
TUBB4A relieves high glucose-induced cardiomyocyte hypertrophy and apoptosis through the regulation of ubiquitination and activation of the NOTCH signaling pathway.TUBB4A通过调节泛素化和激活NOTCH信号通路减轻高糖诱导的心肌细胞肥大和凋亡。
Cytotechnology. 2025 Jun;77(3):100. doi: 10.1007/s10616-025-00763-1. Epub 2025 May 14.
10
Network pharmacology and experimental validation to investigate the mechanism of action of Zhilong Huoxue Tongyu capsule in the prevention and treatment of diabetic cardiomyopathy.基于网络药理学和实验验证探讨蛭龙活血通瘀胶囊防治糖尿病心肌病的作用机制
PLoS One. 2025 May 15;20(5):e0323745. doi: 10.1371/journal.pone.0323745. eCollection 2025.